Shire and Noven have voluntarily withdrawn batches of the ADHD drug Daytrana for the second time in 12 months due to ongoing problems with the product’s release liner.
India’s Dishman Pharmaceuticals is eyeing up the lucrative oncology market to further its development as one of the region's major CRAM firms, according to company managing director Rajnikant Vyas.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from innovatis, Stäubli, GE and Sterilin.
Drug delivery specialist Eurand is to begin supplying its extended release formulation of cyclobenzaprine HCl to South Korea’s Daewoong Pharmaceuticals.
Supply chain specialist MD Logistics is planning to set up a further distribution plant in Indiana, US, specifically targeted at pharmaceutical customers.
Galapagos has bolstered the portfolio of its BioFocus DPI contract services unit by purchasing the structure-based drug discovery business of UK firm Sareum.
A new study by US contract services giant Parexel International reveals that the number of marketing applications for NMEs in the US grew 33 per cent in 2007.
Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.
The US Food and Drug Administration (FDA) has ordered the seizure of $74,000 worth of Xiadafil VIP tablets after SEI Pharmaceuticals refused to withdraw them from the market.
Researchers claim to have developed a drug delivery system capable of passing through the mucus barrier, which had previously been impenetrable to therapeutics.
in-PharmaTechnologist.com’s periodic round-up of employment developments in the pharmaceutical manufacturing industry includes news on Abbott, Pfizer, Gilead and Clarcor.
Sancilio & Co (SCI) says that its new contract manufacturing plant in Riviera Beach, Florida can provide pharmaceutical manufacturers with small batch production capacity for drug tablets and capsules.
Stemcell Technologies has launched a new well plate that promises to enable researchers to improve the process of differentiating stem cells into mature cell lines.
Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.
US researchers have developed a new technique that has enabled them to determine the structure of membrane proteins without having to first crystallise the samples.
Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.
AstraZeneca and Singapore’s National Cancer Centre (NCCS) have selected inoperable hepatocellular carcinoma (HCC) as the first target for their new drug collaboration.
Sweden’s Recipharm hopes that its newly acquired lyophilisation plant will complete its contract services offering and firmly establish it as a player on the CDMO stage.
OIMBL’s PharmaSense is a versatile MRI tool that allows drugmakers to assess tablet dynamics and potentially improve API delivery, according to company managing director Frank Trundle.
The revelation that 49 infants died during clinical trials in India has sparked anger among the nation’s congress, with some calling for all studies to be stopped while investigations take place despite the trials having an infant mortality rate (IMR)...
US-based biotech ArmaGen Technologies has received funding from the Michael J Fox Foundation (MJFF) for the development of its drug delivery technology.
APP Pharmaceuticals, currently the sole supplier of therapeutic heparin vials to the US market, has received FDA approval to manufacture three new formulations of the blood-thinner at its plant in Barceloneta, Puerto Rico.
People employed in the pharmaceutical industry in New Jersey, USA fell by one per cent in 2007, according to a report by the HealthCare Institute of New Jersey (HINJ).
US researchers have developed a chemoenzymatic strategy to synthesise the anticoagulant drug heparin and avoid the contaminant that has killed more than 80 people.
Cardinal Health’s announcement that it is considering spinning off some of its divisions has provoked fevered speculation among industry analysts and media observers alike.
CRO Rubicon Research and chemicals manufacturer Mallinckrodt Baker are teaming up to develop the PanExcea excipient range, which was launched by the latter firm’s parent company Covidien in July.
Conformia says that the integration of its SOA data platform into IBM’s system will provide drugmakers with robust management architecture for the entire lifecycle of a product.
The impact counterfeit pharmaceuticals can have on a company’s sales has been highlighted by Tongjitang Chinese Medicines’ (TCM) second quarter results.
in-PharmaTechnologist.com presents its round up of the latest developments in contract research, including CTI partnering to access Latin America, Encorium signing contracts worth $13.5m and Omnicare setting up in Sweden.
in-PharmaTechnologist.com's round-up of developments in pharmaceutical manufacturing features news of SAFC’s new highly potent API plant, ISPE’s Facility of the Year Awards and Israel’s proposed entry into PIC/S.
Advalytix’ AmpliGrid technology is playing a key role in enabling researchers to discover how just a single cell can lay a huge role in complex biological systems.
Researchers have used Affymetrix Genome-Wide Human SNP (single nucleotide polymorphism) arrays to discover genetic variations that increase the risk of schizophrenia.
Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.
German biotech and life science laboratory services firm AgenoLab has installed the first xCelligence real-time cell analysis system to bolster its assay offering to customers.
in-PharmaTechnologist.com’s latest round up of developments in the field of pharmaceutical packaging includes 3S’ counterfeit solution and new machines for Xcelience and Medica.
US-based DSM Biologics and MorphoSys are teaming up to manufacture the MOR202 antibody, which has shown considerable promise as a treatment for multiple myeloma (MM).
San Antonio-headquartered manufacturing firm DPT Laboratories has won a long-term contract to produce stocks of CPEX Pharmaceuticals’ candidate intranasal insulin product Nasulin for clinical trials.
Sanofi Aventis has extended its deal with China’s NovaMed, adding the anti-convulsant Depakine (valproic acid) to the latter firm’s distribution roster.
Australia’s CSL Ltd has signed a $3.1bn agreement to acquire Talecris Biotherapeutics of the US and throw down the gauntlet to rival Baxter International in the plasma-based pharmaceutical sector.
An insurance policy intended to cover against the pitfalls faced by pharmaceutical manufacturers and distributors has been launched by Lloyds’ underwriter Kiln and broker Jardine Lloyd Thompson (JLT).
Siemens has outlined plans to establish itself as a leading provider of radiopharmaceuticals in India through the construction of numerous manufacturing facilities.
Venus Remedies’ oncology facility has received EMEA GMP accreditation, making it one of very few Indian contract manufacturers licensed to make cancer treatments for the European market.
A new report predicts that current global sales leader Pfizer will relinquish its position by 2014 leaving European pharmaceutical producers like Roche and Sanofi-Aventis free to vie for the top spot.